Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Amir M Arain. (2009) Pregabalin in the management of partial epilepsy. Neuropsychiatric Disease and Treatment 5, pages 407-413.
Read now
Read now
Articles from other publishers (23)
Rehab Moussa Tony, Mohamed A. El Hamd, Mohammed Gamal, Safaa F. Saleh, Nujud Maslamani, Wejdan T. Alsaggaf & Mohamed B. El-Zeiny. (2023) Green Bio-Analytical Study of Gabapentin in Human Plasma Coupled with Pharmacokinetic and Bioequivalence Assessment Using UPLC-MS/MS. Separations 10:4, pages 234.
Crossref
Crossref
Daniel Komisarek, Takin Haj Hassani Sohi & Vera Vasylyeva. (2022) Co-crystals of zwitterionic GABA API's pregabalin and phenibut: properties and application. CrystEngComm 24:48, pages 8390-8398.
Crossref
Crossref
Ahmed E. Elsukary, Ahmed M. N. Z. Helaly, Amal A. El Bakary, Maha E. Moustafa & Mohammad A. El-Kattan. (2022) Comparative Study of the Neurotoxic Effects of Pregabalin Versus Tramadol in Rats. Neurotoxicity Research 40:5, pages 1427-1439.
Crossref
Crossref
Mariangela Panebianco, Rebecca Bresnahan & Anthony G Marson. (2022) Pregabalin add-on for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews 2022:4.
Crossref
Crossref
Mahindra Chincholkar. (2020) Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. British Journal of Pain 14:2, pages 104-114.
Crossref
Crossref
Zeinab M. Awwad, Samar O. El-Ganainy, Ahmed I. ElMallah, Mahmoud M. Khattab & Aiman S. El-Khatib. (2019) Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats. Toxicology 428, pages 152310.
Crossref
Crossref
Milica Stanojevic & Dragan Panic. (2019) Treatment of Anxiety Disorders - The Role of Pharmacists. Serbian Journal of Experimental and Clinical Research 0:0.
Crossref
Crossref
Mariangela Panebianco, Rebecca Bresnahan, Karla Hemming & Anthony G Marson. (2019) Pregabalin add-on for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Manar A. Nader, Hayam Ateyya, Mohamed El-Shafey & Nagla A. El-Sherbeeny. (2018) Sitagliptin enhances the neuroprotective effect of pregabalin against pentylenetetrazole-induced acute epileptogenesis in mice: Implication of oxidative, inflammatory, apoptotic and autophagy pathways. Neurochemistry International 115, pages 11-23.
Crossref
Crossref
Fei Li, Jianxiong Ma, Mingjie Kuang, Xuan Jiang, Ying Wang, Bin Lu, Xingwen Zhao, Lei Sun & Xinlong Ma. (2017) The efficacy of pregabalin for the management of postoperative pain in primary total knee and hip arthroplasty: a meta-analysis. Journal of Orthopaedic Surgery and Research 12:1.
Crossref
Crossref
Itefaq Hussain Qureshi, Azra Riaz, Rafeeq Alam Khan & Afaq Ahmed Siddiqui. (2017) Synergistic anticonvulsant effects of pregabalin and amlodipine on acute seizure model of epilepsy in mice. Metabolic Brain Disease 32:4, pages 1051-1060.
Crossref
Crossref
Harjeet Kaur, Baldeep Kumar & Bikash Medhi. (2016) Antiepileptic drugs in development pipeline: A recent update. eNeurologicalSci 4, pages 42-51.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
155
177
.
Sylvain Rheims & Philippe Ryvlin. 2015. The Treatment of Epilepsy. The Treatment of Epilepsy
595
605
.
Sheila A Lewis. (2014) Newer drug treatments for focal-onset epilepsy. British Journal of Neuroscience Nursing 10:1, pages 6-12.
Crossref
Crossref
G. Zaccara, F. Giovannelli, M. Cincotta, A. Verrotti & E. Grillo. (2013) The adverse event profile of perampanel: meta-analysis of randomized controlled trials. European Journal of Neurology 20:8, pages 1204-1211.
Crossref
Crossref
Stephen M. Stahl, Frank Porreca, Charles P. Taylor, Raymond Cheung, Andrew J. Thorpe & Andrew Clair. (2013) The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?. Trends in Pharmacological Sciences 34:6, pages 332-339.
Crossref
Crossref
Gaetano Zaccara, Piero Perucca, Giulia Loiacono, Fabio Giovannelli & Alberto Verrotti. (2013) The adverse event profile of lacosamide: A systematic review and meta-analysis of randomized controlled trials. Epilepsia 54:1, pages 66-74.
Crossref
Crossref
Leopoldo Rivera-Castaño, Raul Leal-Cantu, Paula Abreu, Marita Guerrero & Gabriela Davila. (2012) A 21-week open-label clinical trial of pregabalin as adjunctive therapy in partial seizures at multiple centers in Mexico (PREPS Mexico). Epilepsy Research 100:1-2, pages 74-79.
Crossref
Crossref
Stefanos Tsounis, Vasilios K. Kimiskidis, Dimitrios Kazis, Konstantinos Gkiatas, Kyriakos Garganis, Klimentini Karageorgiou, Stylianos Giannakodimos, Panagiotis Papathanasopoulos, Andreas Plaitakis, Alexandros Papadimitriou, Leonidas Lyras & Birol Emir. (2011) An open-label, add-on study of pregabalin in patients with partial seizures: A multicenter trial in Greece. Seizure 20:9, pages 701-705.
Crossref
Crossref
Gaetano Zaccara, Pierfranco Gangemi, Piero Perucca & Luigi Specchio. (2011) The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials. Epilepsia 52:4, pages 826-836.
Crossref
Crossref
Bettina Schmitz, Georgia Montouris, Barbara Schäuble & Sue Caleo. (2010) Assessing the unmet treatment need in partial-onset epilepsy: Looking beyond seizure control. Epilepsia 51:11, pages 2231-2240.
Crossref
Crossref
P. Ryvlin, R. Kälviäinen, F. Von Raison, S. Giordano, B. Emir & K. Chatamra. (2010) Pregabalin in partial seizures: a pragmatic 21-week, open-label study (PREPS). European Journal of Neurology 17:5, pages 726-732.
Crossref
Crossref